HW
GSK icon

Hancock Whitney’s GSK GSK Stock Holding History

Hancock Whitney’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4,046
Closed -$220K – 628
2022
Q2 		$220K Sell
4,046
-599
-13% -$33.1K 0.01% 599
2022
Q1 		$253K Buy
4,645
+350
+8% +$19K 0.01% 616
2021
Q4 		$237K Sell
4,295
-935
-18% -$48.6K 0.01% 635
2021
Q3 		$250K Buy
+5,230
New +$263K 0.01% 609

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Hancock Whitney's GSK Position: Q3 2022 in Review

Hancock Whitney sold out of GSK (GSK) in Q3 2022, closing a stake of 4,046 shares — an estimated $220K sold.

Hancock Whitney first reported a position in GSK in Q3 2021 and held it in 4 quarters. The position peaked at $253K in Q1 2022. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

  • Hancock Whitney reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
  • Hancock Whitney sold 4,046 GSK shares in Q3 2022, an estimated $220K.
  • Hancock Whitney first reported a position in GSK in Q3 2021 and held it in 4 quarters.
  • Hancock Whitney's GSK position peaked at $253K in Q1 2022.
  • 742 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on Hancock Whitney's 13F filing for Q3 2022, filed 26 Oct 2022.